Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I Study of Molecular-Guided Surgery for Pancreatic and Gastrointestinal Neuroendocrine Cancers

Summary

The purpose of this phase I study is to see if the use of 68Gallium- positron emission tomography and computer tomography (PET/CT) scans along with NETSPOT® (Advanced Accelerator Applications USA, Inc.) can better define the localization of Neuroendocrine tumors, enhancing the surgical removal of Neuroendocrine tumors (NETs).

General Information

NCT#: NCT03623984
Study ID: IRB-300001980
Trial Phase: Phase I

Trial Sponsor: University of Alabama
Therapies Used in This Trial: Surgery, Positron Emission Tomography - Computed Tomography (PET/CT), Gallium 68 (Ga-68) dotatate

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search